Protective mechanisms of protocatechuic acid against doxorubicin-induced nephrotoxicity in rat model

References

[1] Refaie MM, Amin EF, El-Tahawy NF, Abdelrahman AM. Possible protective effect of diacerein on doxorubicin-induced nephrotoxicity in rats. J Toxicol 2016;2016:9507563.10.1155/2016/9507563Search in Google Scholar

[2] Mohamed RH, Karam RA, Amer MG. Epicatechin attenuates doxorubicin-induced brain toxicity: critical role of TNF-α, iNOS and NF-κB. Brain Res Bull 2011;86:22–8.10.1016/j.brainresbull.2011.07.001Search in Google Scholar

[3] Xong X, Ren Y, Zhang J, Wang G, Han X, Zheng W, et al. Targeted delivery of doxorubicin to breast cancer cells by aptamer functionalized. Oncol Rep 2015;34:1953–60.10.3892/or.2015.4136Search in Google Scholar

[4] Saad SY, Najjar TA, Al-Rykaby AC. The preventive role of deferoxamine against acute doxorubicin-induced kidney, renal and hepatotoxicity in rats. Pharmacol Res 2001;43:211–8.10.1006/phrs.2000.0769Search in Google Scholar

[5] Ghibu S, Delemasure S, Richard C. General oxidative stress during doxorubicin-induced cardiotoxicity in rats: absence of cardioprotection and low antioxidant efficiency of alpha-lipoic acid. Biochimie 2011;4:932–9.10.1016/j.biochi.2011.02.015Search in Google Scholar

[6] Lee VW, Harris DC. Adriamycin nephropathy: a model of focal segmental glomerulosclerosis. Nephrology 2011;16:30–8.10.1111/j.1440-1797.2010.01383.xSearch in Google Scholar

[7] El-Sheikh AA, Morsy MA, Mahmoud MM, Rifaai RA, Abdelrahman AM. Effect of Coenzyme-Q10 on doxorubicin-induced nephrotoxicity in rats. Adv Pharm Sci 2012;2012:981461.10.1155/2012/981461Search in Google Scholar

[8] Injac R, Radic N, Govedarica B, Perse M, Cerar A, Djordjevic A, et al. Acute doxorubicin pulmotoxicity in rats with malignant neoplasm is effectively treated with fullerenol C₆₀(OH)₂₄ through inhibition of oxidative stress. Pharmacol Rep 2009;61:335–42.10.1016/S1734-1140(09)70041-6Search in Google Scholar

[9] Kakkar S, Bais S. A review on protocatechuic acid and its pharmacological potential. ISRN Pharmacol 2014;2014:1–9.10.1155/2014/952943Search in Google Scholar PubMed PubMed Central

[10] Menna P, Salvatorelli E, Cairo G, Gianni L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 2004;256:185–229.10.1124/pr.56.2.6Search in Google Scholar PubMed

[11] Yilmaz S, Atessahin A, Sahna E, Karahan I, Ozer S. Protective effect of lycopene on adriamycin-induced cardiotoxicity and nephrotoxicity. Toxicol 2006;218:164–71.10.1016/j.tox.2005.10.015Search in Google Scholar

[12] Granados-Principal S, Quiles JL, Ramirez-Tortosa CL, Sanchez-Rovira P, Ramirez-Tortosa M. New advances in molecular mechanisms and the prevention of adriamycin toxicity by antioxidant nutrients. Food Chem Toxicol 2010;48:1425–38.10.1016/j.fct.2010.04.007Search in Google Scholar

[13] Vitaglione P, Donnarumma G, Napolitano A, Galvano F, Gallo A, Scalfi L. Protocatechuic acid is the major human metabolite of cyaniding glucosides. J Nutr 2007;137:2043–8.10.1093/jn/137.9.2043Search in Google Scholar

[14] Masella R, Cantafora A, Modesti D, Cardilli A, Gennaro L, Bocc A, et al. Antioxidant activity of 3,4-DHPEA-EA and protocatecuic acid: a comparative assessment with other olive oil biophenols redox reports. Redox Rep 1999;4:113–21.10.1179/135100099101534792Search in Google Scholar

[15] Ueda J, Saito N, Shimazu Y, Ozawa TA. Comparison of the scavenging abilities of antioxidants against hydroxyl radicals. Arch Biochem Biophys 1996;333:77–84.10.1006/abbi.1996.0404Search in Google Scholar

[16] Liu WH, Lin CC, Wang ZH, Mong MC, Yin MC. Effects of protocatechuic acid on trans fat induced hepatic steatosis in mice. J Agric Food Chem 2010;58:10247–52.10.1021/jf102379nSearch in Google Scholar

[17] Harini R, Pugalendi KV. Antioxidant and antihyperlipidaemic activity of protocatechuic acid on streptozotocin diabetic rats. Redox Rep. 2010;15:71–80.10.1179/174329210X12650506623285Search in Google Scholar

[18] Adefegha SA, Oboh G, Omojokun OS, Adefegha OM. Alterations of Na+/K+-ATPase, cholinergic and antioxidant enzymes activity by protocatechuic acid in cadmium-induced neurotoxicity and oxidative stress in Wistar rats. Biomed Pharmacother 2016;83:559–68.10.1016/j.biopha.2016.07.017Search in Google Scholar

[19] Farombi OE, Adedara IA, Awoyemi O, Njoku C, Micah G, Esogwa C, et al. Dietary protocatechuic acid ameliorates dextran sulphate sodium-induced ulcerative colitisand hepatotoxicity in rats. Food Funct 2015;7:913–21.10.1039/C5FO01228GSearch in Google Scholar

[20] European Union. Directive 2010/63/EU of the European parliament and of the council of 22 September 2010 on the protection of animals used for scientific purposes. Official Journal of the European Union 2010 Oct 20 (No. L 276/33).Search in Google Scholar

[21] Misra HP, Fridovich I. The generation of superoxide radical during the antioxidant of hemoglobin. J Biol Chem. 1972;247:6960–62.10.1016/S0021-9258(19)44679-6Search in Google Scholar

[22] Asru KS. Colorimetric assay of catalase. Anal Biochem 1972;47:389–94.10.1016/0003-2697(72)90132-7Search in Google Scholar

[23] Lawerence RA, Burk RF. Glutathione peroxidase activity in selenium-deficient rat’s liver. Biochem Biophys Res Commun. 1961;71:952–58.10.1016/0006-291X(76)90747-6Search in Google Scholar

[24] Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with folin phenol reagent. J Biol Chem. 1951;193:265–75.10.1016/S0021-9258(19)52451-6Search in Google Scholar

[25] Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351–58.10.1016/0003-2697(79)90738-3Search in Google Scholar

[26] Adam-Vizi V, Seregi M. Receptor dependent stimulatory effect of noradrenaline on Na+/K+ ATPase in rat brain homogenate: role of lipid peroxidation. Biochem Pharmacol. 1982;31:2231–36.10.1016/0006-2952(82)90106-XSearch in Google Scholar

[27] Jollow DJ, Mitchell JR, Zampaglione N, Gillette JR. Bromobenzene induced liver necrosis: protective role of glutathione and evidence for 3,4 bromobenzene oxide as the hepatotoxic metabolite. Pharmacol. 1974;11:151–69.10.1159/000136485Search in Google Scholar PubMed

[28] Disbrey BD, Rack JH. Book of histological laboratory methods, Harcourt Brace/Churchill Livingstone, London, 1970.Search in Google Scholar

[29] Betty RK, Jonathan AC. Essential medical statistics, 2nd ed. USA: Blackwell Science, 2003:15–409.Search in Google Scholar

[30] Hertzan-Levy S, Fish R, Skutelsky E, Wollman Y, Chernichovsky T, Polak-Charcon S, et al. Glomerular basement membrane anionic sites in Adriamycin nephropathy: effect of saline loading and nitric oxide modulation. Nephron 2000;84:354–61.10.1159/000045611Search in Google Scholar PubMed

[31] Wang Y, Wang YP, Tay YC, Harris DC. Progressive adriamycin nephropathy in mice: sequence of histologic and immunohistochemical events. Kidney Int 2000;58:1797–804.10.1046/j.1523-1755.2000.00342.xSearch in Google Scholar PubMed

[32] Carvalho C, Santos RX, Cardoso S, Correia S, Oliveira PJ, Santos MS, et al. Doxorubicin: the good, the bad and the ugly effect. Curr Med Chem 2009;16:3267–85.10.2174/092986709788803312Search in Google Scholar PubMed

[33] Farombi EO, Shrotriya S, Surh YJ. Kolaviron inhibits dimethyl nitrosamine- induced liver injury by suppressing COX-2 and iNOS expression via NF-κB and AP-1. Life Sci 2009;84:149–55.10.1016/j.lfs.2008.11.012Search in Google Scholar PubMed

[34] Sayed-Aimed MM. Increased plasma endothelin-1 and cardiac nitric oxide during doxorubicin-induced cardiomyopathy. Pharm Toxicol. 2001;89:140–44.10.1034/j.1600-0773.2001.d01-148.xSearch in Google Scholar

[35] Pacher P, Liaudet L, Bai P. Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction. Circulation 2003;107:896–904.10.1161/01.CIR.0000048192.52098.DDSearch in Google Scholar

[36] Rehman MU, Tahir M, Khan AQ, Khan R, Hamiza OO, Lateef A, et al. D-limonene suppresses doxorubicin-induced oxidative stress and inflammation via repression of COX-2, iNOS, and NFiB in kidneys of Wistar rats. Exp Bio Med 2014;239:465–76.10.1177/1535370213520112Search in Google Scholar

[37] El-Sayed ES, Mansour AM, El-Sawy WS. Nephroprotective effect of Proanthocyanidins against doxorubicin-induced nephrotoxicity in rats. J Biochem Mol Toxicol. 2017;31(11):1–6. DOI: 10.1002/jbt.21965.Search in Google Scholar

[38] Zhu J, Zhang J, Xiang D, Zhang Z, Zhang L, Wu M, et al. Recombinant human interleukin-1 receptor antagonist protects mice against acute doxorubicin-induced cardiotoxicity. Eur J Pharmacol 2010;643:247–53.10.1016/j.ejphar.2010.06.024Search in Google Scholar

[39] Abo-Salem OM. The Protective effect of Aminoguanidine on doxorubicin-induced nephropathy in rats. J Biochem Mol Toxicol 2012;26:1–7.10.1002/jbt.20422Search in Google Scholar

[40] Chen CT, Wang ZH, Hsu CC, Lin HH, Che JH. In vivo protective effects of Diosgenin against doxorubicin-induced cardiotoxicity. Cardiovasc Toxicol 2013;13:185–93.10.3390/nu7064938Search in Google Scholar

[41] Mansour MA, El-Kashef HA, Al-Shabanah OA. Effect of captopril on doxorubicin-induced nephrotoxicity in normal rats. Pharmacol Res. 1999;39:233–37.10.1006/phrs.1998.0432Search in Google Scholar

[42] De Beer EL, Bottone AE, Voest EE. Doxorubicin and mechanical performance of cardiac rabeculae after acute and chronic treatment: a review. Eur J Pharmacol 2001;415:1–11.10.1016/S0014-2999(01)00765-8Search in Google Scholar

[43] Semaming Y, Pannengpetch P, Chattipakorn SC, Chattipakorn N. Pharmacological properties of protocatechuic acid and its potential roles as complementary medicine. Evid-Based Complement Alternat Med 2015;2015:593902.10.1155/2015/593902Search in Google Scholar PubMed PubMed Central

[44] Lee SH, Choi BY, Kho AR, Jeong JH, Hong DK, Lee SH, et al. Protective effects of Protocatechuic acid on seizure-induced neuronal death. Int J Mol Sci 2018;19:E87.10.3390/ijms19010187Search in Google Scholar PubMed PubMed Central

[45] Adefegha SA, Oboh G, Omojokun OS. Modulatory effect of protocatechuic acid on cadmium induced nephrotoxicity and hepatoxicity in rats in vivo. Springerplus 2015;4:619.10.1186/s40064-015-1408-6Search in Google Scholar PubMed PubMed Central